These alterations reduce muscle oxidative capacity while at the same time increasing anaerobic and glycolytic capacities and are responsible for metabolic dysfunction since they cause microinflammation, insulin resistance, and a decrease in the expression/activity of muscle LPL [32,33,34,35,36]. This evidence concerns the gene LPL and Insulin resistance.